Clinical trial
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With…
NCT00005996 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00005996 |
|---|---|
| Title | SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study of SU5416 in Combination With Gemcitabine/Cisplatin in Patients With Advanced Solid Tumors |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride, semaxanib |
| First posted | Jul 19, 2004 |
| Last update posted | Dec 19, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: